| 1 | [SID103218455] | Active | Ki | 0.00242 | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting [AID659850, Type: Literature] | 5-hydroxytryptamine receptor 2A [gi:543727] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.00242 [uM] | | BioAssay | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting | | AID | 659850 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | 22268448 | | Data Table |  |
|
| 2 | [SID103218455] | Active | Ki | 0.00242 | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting [AID659850, Type: Literature] | 5-hydroxytryptamine receptor 2A [gi:543727] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.00242 [uM] | | BioAssay | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting | | AID | 659850 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | 22268448 | | Data Table |  |
|
| 3 | [SID103218455] | Active | Ki | 0.00242 | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting [AID659850, Type: Literature] | 5-hydroxytryptamine receptor 2A [gi:543727] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.00242 [uM] | | BioAssay | Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting | | AID | 659850 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | 22268448 | | Data Table |  |
|
| 4 | [SID103218455] | Active | Ki | 0.0049 | Affinity was evaluated by inhibition of [3H]-spiperone binding to COS cells transfected with human dopamine D-4 receptor [AID64202, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.0049 [uM] | | BioAssay | Affinity was evaluated by inhibition of [3H]-spiperone binding to COS cells transfected with human dopamine D-4 receptor | | AID | 64202 | | BioAssay type | Literature | | Target | | | PubMed | 8064797 | | Data Table |  |
|
| 5 | [SID103218455] | Active | Ki | 0.0049 | Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D4 in COS7 cells [AID65954, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.0049 [uM] | | BioAssay | Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D4 in COS7 cells | | AID | 65954 | | BioAssay type | Literature | | Target | | | PubMed | 7861418 | | Data Table |  |
|
| 6 | [SID103218455] | Active | IC50 | 0.006 | Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand [AID5483, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 0.006 [uM] | | BioAssay | Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand | | AID | 5483 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 7 | [SID103218455] | Active | Ki | 0.009 | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting [AID659851, Type: Literature] | D(4) dopamine receptor [gi:1345939] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.009 [uM] | | BioAssay | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting | | AID | 659851 | | BioAssay type | Literature | | Target | D(4) dopamine receptor [gi:1345939] | | PubMed | 22268448 | | Data Table |  |
|
| 8 | [SID103218455] | Active | Ki | 0.009 | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting [AID659851, Type: Literature] | D(4) dopamine receptor [gi:1345939] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.009 [uM] | | BioAssay | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting | | AID | 659851 | | BioAssay type | Literature | | Target | D(4) dopamine receptor [gi:1345939] | | PubMed | 22268448 | | Data Table |  |
|
| 9 | [SID103218455] | Active | Ki | 0.009 | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting [AID659851, Type: Literature] | D(4) dopamine receptor [gi:1345939] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.009 [uM] | | BioAssay | Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting | | AID | 659851 | | BioAssay type | Literature | | Target | D(4) dopamine receptor [gi:1345939] | | PubMed | 22268448 | | Data Table |  |
|
| 10 | [SID103218455] | Active | IC50 | 0.014 | Compound was tested in vitro for its binding affinity towards human Dopamine receptor D4.2 [AID63865, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 0.014 [uM] | | BioAssay | Compound was tested in vitro for its binding affinity towards human Dopamine receptor D4.2 | | AID | 63865 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 11 | [SID103218455] | Active | Ki | 0.015 | Binding affinity towards human 5-hydroxytryptamine 6 receptor [AID6563, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.015 [uM] | | BioAssay | Binding affinity towards human 5-hydroxytryptamine 6 receptor | | AID | 6563 | | BioAssay type | Literature | | Target | | | PubMed | 12825922 | | Data Table |  |
|
| 12 | [SID103218455] | Active | IC50 | 0.018 | In vitro binding affinity towards Alpha-1 adrenergic receptor by the displacement of [3H]prazosin radioligand in rat cortical homogenates [AID36855, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 0.018 [uM] | | BioAssay | In vitro binding affinity towards Alpha-1 adrenergic receptor by the displacement of [3H]prazosin radioligand in rat cortical homogenates | | AID | 36855 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 13 | [SID103218455] | Active | Ki | 0.021 | Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor [AID64197, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.021 [uM] | | BioAssay | Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor | | AID | 64197 | | BioAssay type | Literature | | Target | | | PubMed | 8064797 | | Data Table |  |
|
| 14 | [SID103218455] | Active | Ki | 0.021 | Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells [AID64327, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.021 [uM] | | BioAssay | Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells | | AID | 64327 | | BioAssay type | Literature | | Target | | | PubMed | 7861418 | | Data Table |  |
|
| 15 | [SID103218455] | Active | Ki | 0.021 | In vitro binding affinity towards Dopamine receptor D2 in rat tissue homogenate using [3H]-spiperone as radioligand [AID65733, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.021 [uM] | | BioAssay | In vitro binding affinity towards Dopamine receptor D2 in rat tissue homogenate using [3H]-spiperone as radioligand | | AID | 65733 | | BioAssay type | Literature | | Target | | | PubMed | 14695828 | | Data Table |  |
|
| 16 | [SID103218455] | Active | IC50 | 0.022 | Binding affinity towards human Dopamine receptor D3 [AID64825, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 0.022 [uM] | | BioAssay | Binding affinity towards human Dopamine receptor D3 | | AID | 64825 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 17 | [SID103218455] | Active | Ki | 0.043 | Binding affinity towards rat 5-hydroxytryptamine 7 receptor [AID6648, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.043 [uM] | | BioAssay | Binding affinity towards rat 5-hydroxytryptamine 7 receptor | | AID | 6648 | | BioAssay type | Literature | | Target | | | PubMed | 12825922 | | Data Table |  |
|
| 18 | [SID103218455] | Active | Ki | 0.05 | Binding affinity for human 5-hydroxytryptamine 6 receptor [AID238747, Type: Literature] | 5-hydroxytryptamine receptor 6 [gi:1703010] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.05 [uM] | | BioAssay | Binding affinity for human 5-hydroxytryptamine 6 receptor | | AID | 238747 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | 15771424 | | Data Table |  |
|
| 19 | [SID103218455] | Active | Ki | 0.05 | Binding affinity for human 5-hydroxytryptamine 6 receptor [AID238747, Type: Literature] | 5-hydroxytryptamine receptor 6 [gi:1703010] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.05 [uM] | | BioAssay | Binding affinity for human 5-hydroxytryptamine 6 receptor | | AID | 238747 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | 15771424 | | Data Table |  |
|
| 20 | [SID103218455] | Active | Ki | 0.05 | Binding affinity for human 5-hydroxytryptamine 6 receptor [AID238747, Type: Literature] | 5-hydroxytryptamine receptor 6 [gi:1703010] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | Ki | 0.05 [uM] | | BioAssay | Binding affinity for human 5-hydroxytryptamine 6 receptor | | AID | 238747 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | 15771424 | | Data Table |  |
|
| 21 | [SID103218455] | Active | IC50 | 0.054 | Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2 [AID61306, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 0.054 [uM] | | BioAssay | Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2 | | AID | 61306 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 22 | [SID90341467] | Active | Potency | 0.3981 | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists [AID488983, Type: confirmatory] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 90341467 | | CID | 3964 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists | | AID | 488983 | | BioAssay type | confirmatory | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 23 | [SID90341467] | Active | Potency | 0.3981 | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists [AID488983, Type: confirmatory] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 90341467 | | CID | 3964 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists | | AID | 488983 | | BioAssay type | confirmatory | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 24 | [SID90341467] | Active | Potency | 0.3981 | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists [AID488983, Type: confirmatory] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 90341467 | | CID | 3964 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists | | AID | 488983 | | BioAssay type | confirmatory | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 25 | [SID90341467] | Active | Potency | 0.3981 | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists [AID488983, Type: confirmatory] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 90341467 | | CID | 3964 | | Outcome | Active | | Potency | 0.3981 [uM] | | BioAssay | HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists | | AID | 488983 | | BioAssay type | confirmatory | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 26 | [SID103218455] | Active | IC50 | 1 | Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand [AID5704, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand | | AID | 5704 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 27 | [SID103218455] | Active | IC50 | 1 | Binding affinity towards histamine H1 receptor from rat brain membranes using [3H]mepyramine as radioligand [AID87514, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Binding affinity towards histamine H1 receptor from rat brain membranes using [3H]mepyramine as radioligand | | AID | 87514 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 28 | [SID103218455] | Active | IC50 | 5.5 | Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells [AID141053, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | IC50 | 5.5 [uM] | | BioAssay | Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells | | AID | 141053 | | BioAssay type | Literature | | Target | | | PubMed | 10377229 | | Data Table |  |
|
| 29 | [SID90341467] | Active | Potency | 11.5774 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 90341467 | | CID | 3964 | | Outcome | Active | | Potency | 11.5774 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 30 | [SID50103874] | Active | Potency | 16.3601 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 50103874 | | CID | 3964 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 31 | [SID50104024] | Active | Potency | 16.3601 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 50104024 | | CID | 3964 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 32 | [SID50104025] | Active | Potency | 16.3601 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 50104025 | | CID | 3964 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 33 | [SID50104026] | Active | Potency | 16.3601 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 50104026 | | CID | 3964 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 34 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT6 [AID624192, Type: Literature] | HTR6 gene product [Homo sapiens] [gi:4504545] |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT6 | | AID | 624192 | | BioAssay type | Literature | | Target | HTR6 gene product [Homo sapiens] [gi:4504545] | | PubMed | 15821958 | | Data Table |  |
|
| 35 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT6 [AID624192, Type: Literature] | HTR6 gene product [Homo sapiens] [gi:4504545] |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT6 | | AID | 624192 | | BioAssay type | Literature | | Target | HTR6 gene product [Homo sapiens] [gi:4504545] | | PubMed | 15821958 | | Data Table |  |
|
| 36 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT6 [AID624192, Type: Literature] | HTR6 gene product [Homo sapiens] [gi:4504545] |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT6 | | AID | 624192 | | BioAssay type | Literature | | Target | HTR6 gene product [Homo sapiens] [gi:4504545] | | PubMed | 15821958 | | Data Table |  |
|
| 37 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A [AID624223, Type: Literature] | HTR2A gene product [Homo sapiens] [gi:260099679] |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A | | AID | 624223 | | BioAssay type | Literature | | Target | HTR2A gene product [Homo sapiens] [gi:260099679] | | PubMed | 12629531 | | Data Table |  |
|
| 38 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A [AID624223, Type: Literature] | HTR2A gene product [Homo sapiens] [gi:260099679] |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A | | AID | 624223 | | BioAssay type | Literature | | Target | HTR2A gene product [Homo sapiens] [gi:260099679] | | PubMed | 12629531 | | Data Table |  |
|
| 39 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A [AID624223, Type: Literature] | HTR2A gene product [Homo sapiens] [gi:260099679] |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2A | | AID | 624223 | | BioAssay type | Literature | | Target | HTR2A gene product [Homo sapiens] [gi:260099679] | | PubMed | 12629531 | | Data Table |  |
|
| 40 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2C [AID624209, Type: Literature] | HTR2C gene product [Homo sapiens] [gi:377520139] |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2C | | AID | 624209 | | BioAssay type | Literature | | Target | HTR2C gene product [Homo sapiens] [gi:377520139] | | PubMed | 15322733 | | Data Table |  |
|
| 41 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2C [AID624209, Type: Literature] | HTR2C gene product [Homo sapiens] [gi:377520139] |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2C | | AID | 624209 | | BioAssay type | Literature | | Target | HTR2C gene product [Homo sapiens] [gi:377520139] | | PubMed | 15322733 | | Data Table |  |
|
| 42 | [SID135650533] | Active | | | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2C [AID624209, Type: Literature] | HTR2C gene product [Homo sapiens] [gi:377520139] |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Human 5-Hydroxytryptamine receptor 5-HT2C | | AID | 624209 | | BioAssay type | Literature | | Target | HTR2C gene product [Homo sapiens] [gi:377520139] | | PubMed | 15322733 | | Data Table |  |
|
| 43 | [SID48416188] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 48416188 | | CID | 3964 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID103218455] | Active | | | Binding affinity against human UDP Glucuronosyltransferase 1A4 (UGT1A4) [AID214939, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | BioAssay | Binding affinity against human UDP Glucuronosyltransferase 1A4 (UGT1A4) | | AID | 214939 | | BioAssay type | Literature | | Target | | | PubMed | 12699380 | | Data Table |  |
|
| 45 | [SID103218455] | Active | | | FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase [AID588216, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | BioAssay | FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase | | AID | 588216 | | BioAssay type | Literature | | Target | | | PubMed | 16472241 | | Data Table |  |
|
| 46 | [SID103218455] | Active | | | FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase [AID588217, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | BioAssay | FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase | | AID | 588217 | | BioAssay type | Literature | | Target | | | PubMed | 16472241 | | Data Table |  |
|
| 47 | [SID85209777] | Active | | | Ligands of bioamine (Class A) GPCRs [AID2062, Type: other] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85209777 | | CID | 3964 | | Outcome | Active | | BioAssay | Ligands of bioamine (Class A) GPCRs | | AID | 2062 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID103218455] | Active | | | FDA HLAED, liver enzyme composite activity [AID588214, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103218455 | | CID | 3964 | | Outcome | Active | | BioAssay | FDA HLAED, liver enzyme composite activity | | AID | 588214 | | BioAssay type | Literature | | Target | | | PubMed | 16472241 | | Data Table |  |
|
| 49 | [SID135650533] | Active | | | Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT6 [AID624190, Type: Literature] | Htr6 gene product [Rattus norvegicus] [gi:13242259] |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT6 | | AID | 624190 | | BioAssay type | Literature | | Target | Htr6 gene product [Rattus norvegicus] [gi:13242259] | | PubMed | 9798944 | | Data Table |  |
|
| 50 | [SID135650533] | Active | | | Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT6 [AID624190, Type: Literature] | Htr6 gene product [Rattus norvegicus] [gi:13242259] |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 135650533 | | CID | 3964 | | Outcome | Active | | BioAssay | Antagonists at Rat 5-Hydroxytryptamine receptor 5-HT6 | | AID | 624190 | | BioAssay type | Literature | | Target | Htr6 gene product [Rattus norvegicus] [gi:13242259] | | PubMed | 9798944 | | Data Table |  |
|